Subscribe to RSS
DOI: 10.1055/s-2001-18862
Advances in the Understanding of the Pathogenetic Pathways of Disseminated Intravascular Coagulation Result in More Insight in the Clinical Picture and Better Management Strategies
Publication History
Publication Date:
06 December 2001 (online)
![](https://www.thieme-connect.de/media/sth/200106/lookinside/thumbnails/10.1055-s-2001-18862-1.jpg)
ABSTRACT
Disseminated intravascular coagulation (DIC) is a syndrome characterized by systemic intravascular activation of coagulation leading to widespread deposition of fibrin in the circulation. There is ample experimental and pathological evidence that the fibrin deposition contributes to multiple organ failure. The massive and ongoing activation of coagulation may result in depletion of platelets and coagulation factors, which may cause bleeding (consumption coagulopathy). Recent knowledge on important pathogenetic mechanisms that may lead to DIC has resulted in novel preventive and therapeutic approaches to patients with DIC. DIC is not a disease in itself but is a complication of a variety of disorders. However, the pathogenesis of DIC follows similar pathways in almost all of these situations, with a pivotal role of proinflammatory cytokines. The cornerstone of the management of DIC is the specific and vigorous treatment of the underlying disorder. Strategies aimed at the inhibition of coagulation activation may theoretically be justified and have been found to be beneficial in experimental and initial clinical studies. These strategies comprise inhibition of tissue factor-mediated activation of coagulation and restoration of physiological anticoagulant pathways by means of the administration of (activated) protein C concentrate or antithrombin concentrate.
KEYWORD
Disseminated intravascular coagulation - DIC - multiple organ dysfunction syndrome - MODS - coagulation - cytokines - treatment
REFERENCES
- 1 Levi M, ten Cate H. Disseminated intravascular coagulation. N Engl J Med . 1999; 341 586-592
- 2 Seligsohn U. Disseminated intravascular coagulation. In: Handin RI, Lux SE, Stossel TP, eds. Blood: Principles and Practice of Hematology Philadelphia: Lippincott 2000
- 3 Marder V J, Feinstein D, Francis C, Colman R W. Consumptive thrombohemorrhagic disorders. In: Colman RW, Hirsh J, Marder VJ, Salzman E, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 3rd ed Philadelphia: Lippincott 1994: 1023-1063
- 4 Mammen E F, Anderson G F, Barnard M I. Disseminated intravascular coagulation in man. Thrombosis et Diathesis Haemorrhagica . 1969; 36(Suppl) 171-176
- 5 Levi M, ten Cate H, van der Poll T. Disseminated intravascular coagulation. State of the art. Thromb Haemost . 1999; 82 695-705
- 6 Verstraete M, Vermylen C, Vermylen J. Excessive consumption of blood coagulation components as a cause of hemorraghic diathesis. Am J Med . 1965; 35 899-905
- 7 Rodriguez-Erdmann F. Bleeding due to increased intravascular blood coagulation. Hemorrhagic syndromes caused by consumption of blood-clotting factors (consumption-coagulopathies). N Engl J Med . 1965; 273 1370-1378
- 8 Dupuy M. Injections de matière cérébrale dans les veines. Gaz Med Paris . 1834; 2 524-528
- 9 Trousseau A. Phlegmasia alba dolens. Clin Med Hotel Dieu Paris . 1865; 695
- 10 Ratnoff O D, Pritchard J A, Colopy J E. Hemorraghic states during pregnancy. N Engl J Med . 1955; 253 97-102
- 11 McKay D G. Disseminated Intravascular Coagulation. An Intermediary Mechanism of Disease New York: Hoeber; 1965
- 12 Deykin D. The clinical challenge of disseminated intravascular coagulation. N Engl J Med . 1970; 283 636-644
- 13 Colman R W, Robboy S J, Minna J D. Disseminated intravascular coagulation. A reappraisal. Annu Rev Med . 1979; 30 359-374
- 14 Feinstein D I. Treatment of disseminated intravascular coagulation. Semin Thromb Hemost . 1988; 14 351-362
- 15 Schwartzman R J, Hill J B. Neurologic complications of disseminated intravascular coagulation. Neurology . 1982; 32 791-797
- 16 Merskey C, Johnson A J, Kleiner G J, Wohl H. The defibrination syndrome. Clinical features and laboratory diagnosis. Br J Haematol . 1967; 13 528-549
- 17 Schneider C L. Fibrin embolism with defibrination as one of the end results during placenta abruptio. Surg Gynecol Obstet . 1951; 92 27-34
- 18 Lasch H G, Heene D L, Huth K, Sandritter W. Pathophysiology, clinical manifestations and therapy of consumption-coagulopathy (``Verbrauchskoagulopathie''). Am J Cardiol . 1967; 20 381-391
- 19 Müller-Berghaus G. Pathophysiologic and biochemical events in disseminated intravascular coagulation. Dysregulation of procoagulant and anticoagulant pathways. Semin Thromb Hemost . 1989; 15 58-87
- 20 Müller-Berghaus G, Blombäck M, ten Cate W J. Attempts to define disseminated intravascular coagulation. In: Müller-Berghaus G, Madlener K, Blombäck M, ten Cate JW, eds. DIC. Pathogenesis, Diagnosis and Therapy of Disseminated Intravascular Fibrin Formation Amsterdam: Elsevier Science Publishers 1993: 3
- 21 Brandtzaeg P, Joo G B, Brusletto B, Kierulf P. Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease. Thromb Res . 1990; 57 271-278
- 22 Hesselvik J F, Blombäck M, Brodin B, Maller R. Coagulation, fibrinolysis, and kallikrein systems in sepsis. Relation to outcome. Crit Care Med . 1989; 17 724-733
- 23 Voss R, Matthias F R, Borkowski G, Reitz D. Activation and inhibition of fibrinolysis in septic patients in an internal intensive care unit. Br J Haematol . 1990; 75 99-105
- 24 Alkjaersig N, Fletcher A P, Sherry S. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic (fibrinolytic) states. J Clin Invest . 1962; 41 917-934
- 25 Levi M, van der Poll T, de Jonge E, ten Cate H. Relative insufficiency of fibrinolysis in disseminated intravascular coagulation. Sepsis . 2000; 3 103-109
- 26 Vervloet M G, Thijs L G, Hack C E. Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock. Semin Thromb Hemost . 1998; 24 33-44
- 27 Levi M, van der Poll T, ten Cate H, van Deventer J S. The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia. Eur J Clin Invest . 1997; 27 3-9
- 28 Avvisati G, ten Cate W J, Sturk A. Acquired alpha-2-antiplasmin deficiency in acute promyelocytic leukaemia. Br J Haematol . 1988; 70 43-48
- 29 Dombret H, Scrobohaci M L, Ghorra P. Coagulation disorders associated with acute promyelocytic leukemia. Corrective effect of all-trans retinoic acid treatment. Leukemia . 1993; 7 2-9
- 30 Albarracin N S, Haust M D. Intravascular coagulation in promyelocytic leukemia. A case study including ultrastructure. Am J Clin Pathol . 1971; 55 677-685
- 31 Avvisati G, ten Cate W J, Büller H R, Mandelli F. Tranexamic acid for control of haemorrhage in acute promyelocytic leukaemia. Lancet . 1989; 2 122-124
- 32 Taylor Jr B F, Toh C H, Hoots K, Wada H, Levi M. Towards a definition, clinical and laboratory criteria and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001 (in press).
- 33 Müller-Berghaus G, Levi M, ten Cate H. Disseminated intravascular coagulation. In: Verstraete M, Topol E, Fuster V, eds. Cardiovascular Thrombosis Thrombocardiology. Philadelphia: Lippincott 1998: 781
- 34 Thijs L G, de Boer P J, de Groot M, Hack C E. Coagulation disorders in septic shock. Intensive Care Med . 1993; 19(Suppl 1) S8-15
- 35 Baglin T. Disseminated intravascular coagulation. Diagnosis and treatment. BMJ . 1996; 312 683-687
- 36 Gando S, Kameue T, Nanzaki S, Nakanishi Y. Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome. Thromb Haemost . 1996; 75 224-228
- 37 Bone R C. Gram-positive organisms and sepsis. Arch Intern Med . 1994; 154 26-34
- 38 Bhamarapravati N. Hemostatic defects in Dengue hemorrhagic fever. Rev Infect Dis . 1989; 11(Suppl 4) S826-S829
- 39 Heller M V, Marta R F, Sturk A. Early markers of blood coagulation and fibrinolysis activation in Argentine hemorrhagic fever. Thromb Haemost . 1995; 73 368-373
- 40 Clemens R, Pramoolsinsap C, Lorenz R. Activation of the coagulation cascade in severe falciparum malaria through the intrinsic pathway. Br J Haematol . 1994; 87 100-105
- 41 Mohanty D, Ghosh K, Nandwani S K. Fibrinolysis, inhibitors of blood coagulation, and monocyte derived coagulant activity in acute malaria. Am J Hematol . 1997; 54 23-29
- 42 Fera G, Semeraro N, de Mitrio V, Schiraldi O. Disseminated intravascular coagulation associated with disseminated cryptococcosis in a patient with acquired immunodeficiency syndrome. Infection . 1993; 21 171-173
- 43 Hayes E B, Gubler D J. Dengue and Dengue hemorrhagic fever. Pediatr Infect Dis J . 1992; 11 311-317
- 44 Sumarmo, Wulur H, Jahja E. Clinical observations on virologically confirmed fatal Dengue infections in Jakarta, Indonesia. Bull World Health Organ . 1983; 61 693-701
- 45 Kuberski T, Rosen L, Reed D, Mataika J. Clinical and laboratory observations on patients with primary and secondary Dengue type 1 infections with hemorrhagic manifestations in Fiji. Am J Trop Med Hyg . 1977; 26 775-783
- 46 Egbring R, Slenczka W, Baltzer G. Clinical manifestations and mechanism of the haemorrhagic diathesis in Marburg viral disease. In: Martini GA, Siegert R, eds. Marburg Virus Disease New York: Springer-Verlag 1971: 41
- 47 Gear J S, Cassel G A, Gear A J. Outbreak of Marburg virus disease in Johannesburg. BMJ . 1975; 4 489-493
- 48 WHO International Study Team. Ebola haemorrhagic fever in Sudan. Bull World Health Organ . 1978; 56 247-270
- 49 International Commision. Ebola haemorrhgic fever in Zaire. Bull World Health Organ . 1978; 56 271-293
- 50 Roumen R M, Hendriks T, van der Ven. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg . 1993; 218 769-776
- 51 Colman R W, Rubin R N. Disseminated intravascular coagulation due to malignancy. Semin Oncol . 1990; 17 172-186
- 52 Sarris A H, Kempin S, Berman E. High incidence of disseminated intravascular coagulation during remission induction of adult patients with acute lymphoblastic leukemia. Blood . 1992; 79 1305-1310
- 53 Tytgat G N, Collen D, Verstraete M. Metabolism of fibrinogen in cirrhosis of the liver. J Clin Invest . 1971; 50 169-170
- 54 Coleman M, Finlayson N, Bettigole R E. Fibrinogen survival in cirrhosis. Improvement by ``low dose'' heparin. Ann Intern Med . 1975; 83 79-81
- 55 Carr J M, McKinney M, McDonagh J. Diagnosis of disseminated intravascular coagulation. Role of D-dimer. Am J Clin Pathol . 1989; 91 280-287
- 56 Coccheri S, Mannucci P M, Palareti G. Significance of plasma fibrinopeptide A and high molecular weight fibrinogen in patients with liver cirrhosis. Br J Haematol . 1982; 52 503-509
- 57 Oka K, Tanaka K. Intravascular coagulation in autopsy cases with liver diseases. Thromb Haemost . 1979; 42 564-570
- 58 Tempero M A, Davis R B, Reed E, Edney J. Thrombocytopenia and laboratory evidence of disseminated intravascular coagulation after shunts for ascites in malignant disease. Cancer . 1985; 55 2718-2721
- 59 Szlachetka D M. Kasabach-Merritt syndrome. A case review. Neonatal Network . 1998; 17 7-15
- 60 Gibney E J, Bouchier-Hayes D. Coagulopathy and abdominal aortic aneurysm. Eur J Vasc Surg . 1990; 4 557-562
- 61 Aboulafia D M, Aboulafia E D. Aortic aneurysm-induced disseminated intravascular coagulation. Ann Vasc Surg . 1996; 10 396-405
- 62 Straub P W, Kessler S, Schreiber A, Frick P G. Chronic intravascular coagulation in Kasabach-Merritt syndrome. Preferential accumulation of fibrinogen 131 I in a giant hemangioma. Arch Intern Med . 1972; 129 475-478
- 63 Warrell R PJ, Kempin S J, Benua R S, Reiman R E, Young C W. Intratumoral consumption of indium-111 labeled platelets in a patient with hemangiomatosis and intravascular coagulation (Kasabach-Merritt syndrome). Cancer . 1983; 52 2256-2260
- 64 Neidhart J A, Roach R W. Successful treatment of skeletal hemangioma and Kasabach-Merritt syndrome with aminocaproic acid. Is fibrinolysis ``defensive''?. Am J Med . 1982; 73 434-438
- 65 el-Dessouky M, Azmy A F, Raine P A, Young D G. Kasabach-Merritt syndrome. J Pediatr Surg . 1988; 23 109-111
- 66 D'Amico J A, Hoffman G C, Dyment P G. Klippel-Trenaunay syndrome associated with chronic disseminated intravascular coagulation and massive osteolysis. Cleveland Clin Q . 1977; 44 181-188
- 67 Poon M C, Kloiber R, Birdsell D C. Epsilon-aminocaproic acid in the reversal of consumptive coagulopathy with platelet sequestration in a vascular malformation of Klippel-Trenaunay syndrome. Am J Med . 1989; 87 211-213
- 68 Alpert L I, Benisch B. Hemangioendothelioma of the liver associated with microangiopathic hemolytic anemia. Report of four cases. Am J Med . 1970; 48 624-628
- 69 Bick R L. Hereditary hemorrhagic telangiectasia and disseminated intravascular coagulation. A new clinical syndrome. Ann N Y Acad Sci . 1981; 370 851-854
- 70 de Boer K, ten Cate W J, Sturk A, Borm J J, Treffers P E. Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gynecol . 1989; 160 95-100
- 71 Weiner C P. Preeclampsia-eclampsia syndrome and coagulation. Clin Perinatol . 1991; 18 713-726
- 72 Martin J NJ, Stedman C M. Imitators of preeclampsia and HELLP syndrome. Obstet Gynecol Clin North Am . 1991; 18 181-198
- 73 Weiner C P. The obstetric patient and disseminated intravascular coagulation. Clin Perinatol . 1986; 13 705-717
- 74 McDougall R J, Duke G J. Amniotic fluid embolism syndrome. Case report and review. Anaesthesia Intensive Care . 1995; 23 735-740
- 75 Ruggenenti P, Lutz J, Remuzzi G. Pathogenesis and treatment of thrombotic microangiopathy. Kidney Int . 1997; 58(Suppl) S97-101